Quick Takeaways
- Thomas A. Mccourt has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $9,340,986.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Thomas A. Mccourt and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | Chief Executive Officer, Director | $9,285,317 | -$747,674 | -7.5% | 10 Mar 2026 |
| PLRX | PLIANT THERAPEUTICS, INC. | Director | $55,669 | 05 Jun 2025 | ||
| XLRN | ACCELERON PHARMA INC | Director | 19 Nov 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|